KRAS and neoplasm: While much previous research into cancer has focused on genetic modifications and oncogenes, such as KRAS, it has become increasingly clear that a dynamic ECM and TME co-evolving with tumor cells may have a profound effect on proliferation, immune evasion, and metastasis together with the underlying genetic mutations which support tumor initiation.